04/14/2026

Policies That Strengthen Supply Chains Needed to Mitigate Drug Shortages

ASCO Submits Formal Response to CMS

On March 30, 2026, the Association for Clinical Oncology (ASCO) submitted a formal response to the Centers for Medicare & Medicaid Services (CMS) regarding the Advanced Notice of Proposed Rulemaking on domestic procurement of Personal Protective Equipment and essential medicines. As drug shortages disrupt cancer care and threaten patient outcomes, ASCO continues to advocate for policies that ensure a resilient, reliable, and flexible supply chain. Key priorities included in the Association’s submission are highlighted below.

To read the full article visit ASCO in Action.